Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2019: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2018: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2017: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Outline of Final Research Achievements |
We developed a novel 3C-based approach to detect allele-specific chromatin interactions. Our work illuminates the allelic imbalances in a series of transcriptional regulation from factor binding to gene expression mediated by chromatin interaction underlie the molecular mechanism of 9p21 endometriosis risk locus. Furthermore, we investigated regulatory mechanisms underlying the other endometriosis associated loci. We demonstrated that somatic mutations on cancer-associated genes such as PIK3CA and KRAS were prevalent in epithelial cells in ovarian endometriosis and normal uterine endometrium. Finally, we conducted single endometrial gland RNA-sequencing to evaluate gene expression difference according to somatic mutation status.
|